OR11G2
gene geneOn this page
Summary
OR11G2 (olfactory receptor family 11 subfamily G member 2, HGNC:15346) is a protein-coding gene on chromosome 14q11.2, encoding Olfactory receptor 11G2 (Q8NGC1). Odorant receptor.
Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome.
Source: NCBI Gene 390439 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 52 total
- MANE Select transcript:
NM_001386033
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:15346 |
| Approved symbol | OR11G2 |
| Name | olfactory receptor family 11 subfamily G member 2 |
| Location | 14q11.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000196832 |
| Ensembl biotype | protein_coding |
| Entrez | 390439 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 2 protein_coding
ENST00000641682, ENST00000641879
RefSeq mRNA: 2 — MANE Select: NM_001386033
NM_001005503, NM_001386033
CCDS: CCDS32032
Canonical transcript exons
ENST00000641879 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003811603 | 20190896 | 20191666 |
| ENSE00003812222 | 20197434 | 20201075 |
Expression profiles
Bgee: expression breadth tissue_specific, 4 present calls, max score 74.35.
Top tissues by expression
131 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 74.35 | gold quality |
| sural nerve | UBERON:0015488 | 43.69 | gold quality |
| blood | UBERON:0000178 | 43.55 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 42.56 | silver quality |
| granulocyte | CL:0000094 | 40.70 | gold quality |
| ventricular zone | UBERON:0003053 | 39.91 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 39.14 | gold quality |
| stromal cell of endometrium | CL:0002255 | 39.07 | gold quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| ganglionic eminence | UBERON:0004023 | 37.12 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 36.39 | gold quality |
| bone marrow cell | CL:0002092 | 36.16 | gold quality |
| leukocyte | CL:0000738 | 35.35 | gold quality |
| monocyte | CL:0000576 | 34.78 | gold quality |
| apex of heart | UBERON:0002098 | 34.67 | gold quality |
| muscle tissue | UBERON:0002385 | 34.46 | gold quality |
| right coronary artery | UBERON:0001625 | 33.49 | gold quality |
| prefrontal cortex | UBERON:0000451 | 32.50 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 32.08 | gold quality |
| liver | UBERON:0002107 | 32.05 | gold quality |
| bone marrow | UBERON:0002371 | 31.74 | gold quality |
| gall bladder | UBERON:0002110 | 30.72 | gold quality |
| urinary bladder | UBERON:0001255 | 30.50 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 30.17 | gold quality |
| islet of Langerhans | UBERON:0000006 | 29.21 | gold quality |
| pancreas | UBERON:0001264 | 29.11 | gold quality |
| lymph node | UBERON:0000029 | 28.74 | gold quality |
| frontal cortex | UBERON:0001870 | 28.29 | gold quality |
| calcaneal tendon | UBERON:0003701 | 28.29 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 4.89 |
Regulation
Is transcription factor: no
Cross-species orthologs
1 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Or11g1 | ENSMUSG00000094692 |
Paralogs (33): TACR2 (ENSG00000075073), PROKR2 (ENSG00000101292), GPR50 (ENSG00000102195), TACR1 (ENSG00000115353), GPR75 (ENSG00000119737), PRLHR (ENSG00000119973), GPR83 (ENSG00000123901), MCHR1 (ENSG00000128285), OR11H1 (ENSG00000130538), MTNR1B (ENSG00000134640), MCHR2 (ENSG00000152034), NPY1R (ENSG00000164128), NPY5R (ENSG00000164129), MTNR1A (ENSG00000168412), PROKR1 (ENSG00000169618), TACR3 (ENSG00000169836), OR9G1 (ENSG00000174914), OR11H4 (ENSG00000176198), OR11H6 (ENSG00000176219), OR9A2 (ENSG00000179468), GPR88 (ENSG00000181656), GPR19 (ENSG00000183150), NPY2R (ENSG00000185149), NPY4R (ENSG00000204174), OR11A1 (ENSG00000204694), OR9A1P (ENSG00000237621), OR11H12 (ENSG00000257115), OR9A4 (ENSG00000258083), OR11H2 (ENSG00000258453), OR11H7 (ENSG00000258806), NPY4R2 (ENSG00000264717), OR10X1 (ENSG00000279111), OR51F1 (ENSG00000280021)
Protein
Protein identifiers
Olfactory receptor 11G2 — Q8NGC1 (reviewed: Q8NGC1)
Alternative names: Olfactory receptor OR14-34
All UniProt accessions (1): A0A126GWS8
UniProt curated annotations — full annotation on UniProt →
Function. Odorant receptor.
Subcellular location. Cell membrane.
Similarity. Belongs to the G-protein coupled receptor 1 family.
RefSeq proteins (2): NP_001005503, NP_001372962* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000276 | GPCR_Rhodpsn | Family |
| IPR000725 | Olfact_rcpt | Family |
| IPR017452 | GPCR_Rhodpsn_7TM | Domain |
| IPR050939 | Olfactory_GPCR1 | Family |
Pfam: PF13853
UniProt features (20 total): topological domain 8, transmembrane region 7, sequence variant 2, chain 1, glycosylation site 1, disulfide bond 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8NGC1-F1 | 81.65 | 0.49 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Disulfide bonds (1): 135–217
Glycosylation sites (1): 43
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-9752946 | Expression and translocation of olfactory receptors |
MSigDB gene sets: 18 (showing top):
GOBP_SENSORY_PERCEPTION_OF_CHEMICAL_STIMULUS, KEGG_OLFACTORY_TRANSDUCTION, GOBP_DETECTION_OF_STIMULUS, GOBP_SENSORY_PERCEPTION, GOMF_OLFACTORY_RECEPTOR_ACTIVITY, GOMF_TRANSMEMBRANE_SIGNALING_RECEPTOR_ACTIVITY, GOMF_G_PROTEIN_COUPLED_RECEPTOR_ACTIVITY, GOBP_SENSORY_PERCEPTION_OF_SMELL, GOBP_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY, GOBP_DETECTION_OF_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION, REACTOME_OLFACTORY_SIGNALING_PATHWAY, REACTOME_SENSORY_PERCEPTION, ZHANG_FH_DEFICIENT_RCC_C2_VS_OTHERS_UP, GOBP_DETECTION_OF_CHEMICAL_STIMULUS, GOMF_MOLECULAR_TRANSDUCER_ACTIVITY
GO Biological Process (4): signal transduction (GO:0007165), G protein-coupled receptor signaling pathway (GO:0007186), sensory perception of smell (GO:0007608), detection of chemical stimulus involved in sensory perception of smell (GO:0050911)
GO Molecular Function (2): G protein-coupled receptor activity (GO:0004930), olfactory receptor activity (GO:0004984)
GO Cellular Component (2): plasma membrane (GO:0005886), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Olfactory Signaling Pathway | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| transmembrane signaling receptor activity | 2 |
| cell communication | 1 |
| cellular process | 1 |
| signaling | 1 |
| regulation of cellular process | 1 |
| cellular response to stimulus | 1 |
| G protein-coupled receptor activity | 1 |
| signal transduction | 1 |
| sensory perception of chemical stimulus | 1 |
| sensory perception of smell | 1 |
| detection of chemical stimulus involved in sensory perception | 1 |
| G protein-coupled receptor signaling pathway | 1 |
| detection of chemical stimulus involved in sensory perception of smell | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
288 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| OR11G2 | PRSS48 | Q7RTY5 | 572 |
| OR11G2 | STPG1 | Q5TH74 | 419 |
| OR11G2 | PRSS55 | Q6UWB4 | 411 |
| OR11G2 | CRYBG2 | Q8N1P7 | 395 |
| OR11G2 | ZKSCAN8 | Q15776 | 377 |
| OR11G2 | MARCHF10 | Q8NA82 | 371 |
| OR11G2 | WFDC3 | Q8IUB2 | 370 |
| OR11G2 | SHROOM1 | Q2M3G4 | 370 |
| OR11G2 | ZCCHC2 | Q9C0B9 | 369 |
| OR11G2 | USF3 | Q68DE3 | 367 |
| OR11G2 | RNASE13 | Q5GAN3 | 359 |
| OR11G2 | AP5B1 | Q2VPB7 | 350 |
| OR11G2 | TSC22D2 | O75157 | 349 |
| OR11G2 | ZNF717 | Q9BY31 | 348 |
| OR11G2 | SPICE1 | Q8N0Z3 | 333 |
IntAct
2 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| OR11G2 | MLNR | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (4): SLC26A4 (Affinity Capture-MS), ESRRB (Affinity Capture-MS), MLNR (Affinity Capture-MS), HPCAL4 (Affinity Capture-MS)
ESM2 similar proteins: A6ND48, A6NFC9, B2RN74, O43869, O60412, O60431, P23265, P31388, P34987, P47883, P47884, P47887, P58170, Q0VAX9, Q5JRS4, Q60894, Q6IFN5, Q7Z3T1, Q8NG78, Q8NG84, Q8NG94, Q8NG99, Q8NGC0, Q8NGC1, Q8NGC5, Q8NGE7, Q8NGG2, Q8NGG3, Q8NGN1, Q8NGN2, Q8NGR1, Q8NGR2, Q8NGR6, Q8NGT2, Q8NGW1, Q8NGW6, Q8NGZ2, Q8NGZ5, Q8NH06, Q8NH07
Diamond homologs: A3KFT3, A4D2G3, A6NH00, A6NL26, A6NM03, O43869, O76000, O76001, O76002, O95006, O95371, O95918, P0C629, P0C645, P0C7T2, P23266, P23275, P34984, P58181, P59922, Q13607, Q5JQS5, Q5TZ20, Q60883, Q60890, Q6IEZ7, Q6IF00, Q7TR96, Q7Z3T1, Q8N349, Q8N628, Q8NG76, Q8NG77, Q8NG80, Q8NG81, Q8NG83, Q8NG84, Q8NG85, Q8NG97, Q8NGC0
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
52 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 47 |
| Likely benign | 5 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
312 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 14:20198056:A:G | acceptor_gain | 0.8100 |
| 14:20198108:T:TA | acceptor_gain | 0.7800 |
| 14:20198053:T:G | donor_gain | 0.7300 |
| 14:20198094:G:A | acceptor_gain | 0.7200 |
| 14:20198053:T:TG | donor_gain | 0.7100 |
| 14:20198057:G:GG | acceptor_gain | 0.7100 |
| 14:20198089:A:AG | acceptor_gain | 0.7100 |
| 14:20198103:T:G | acceptor_gain | 0.7100 |
| 14:20197513:G:T | donor_gain | 0.6700 |
| 14:20198256:A:T | donor_gain | 0.6500 |
| 14:20198093:T:TA | acceptor_gain | 0.6400 |
| 14:20198207:GC:G | donor_gain | 0.6400 |
| 14:20197657:GAGA:G | donor_gain | 0.6200 |
| 14:20198050:GTCT:G | donor_gain | 0.6200 |
| 14:20198051:TCTT:T | donor_gain | 0.6200 |
| 14:20198089:ATTGT:A | acceptor_gain | 0.6200 |
| 14:20198205:C:CA | acceptor_gain | 0.6200 |
| 14:20198208:C:G | donor_gain | 0.6200 |
| 14:20197512:G:GT | donor_gain | 0.6100 |
| 14:20198102:A:AG | acceptor_gain | 0.6100 |
| 14:20198126:TGAGG:T | acceptor_gain | 0.6000 |
| 14:20198127:GAGGG:G | acceptor_gain | 0.6000 |
| 14:20197660:A:G | donor_gain | 0.5900 |
| 14:20198206:G:A | acceptor_gain | 0.5900 |
| 14:20198222:T:G | donor_gain | 0.5900 |
| 14:20198091:T:A | acceptor_gain | 0.5800 |
| 14:20198228:G:GT | donor_gain | 0.5800 |
| 14:20197625:T:G | donor_gain | 0.5700 |
| 14:20198089:ATT:A | acceptor_gain | 0.5700 |
| 14:20198090:T:G | acceptor_gain | 0.5700 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000184964 (14:20191227 A>G), RS1000237435 (14:20191585 C>G), RS1000467115 (14:20200672 G>T), RS1000737366 (14:20188987 T>A), RS1001191102 (14:20189216 G>A), RS1001334270 (14:20198529 C>A,G), RS1001632450 (14:20200385 G>A), RS1001966532 (14:20194189 T>A,C), RS1002172082 (14:20193848 G>A,C), RS1002576600 (14:20198833 A>C), RS1002781386 (14:20199491 G>A), RS1002966606 (14:20192826 G>A), RS1003043497 (14:20198980 T>C), RS1003175391 (14:20195375 T>C), RS1003312505 (14:20195146 A>G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
9 total (human), top 9 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| butyraldehyde | increases expression | 1 |
| maleic acid | increases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Benzo(a)pyrene | decreases methylation, increases methylation | 1 |
| Cadmium | decreases expression, increases abundance | 1 |
| Plant Extracts | decreases expression, affects cotreatment | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
| Cadmium Chloride | decreases expression, increases abundance | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.